Literature DB >> 25131394

Heterozygous FGF8 mutations in patients presenting cryptorchidism and multiple VATER/VACTERL features without limb anomalies.

Claudia Zeidler1, Joachim Woelfle, Markus Draaken, Sadaf S Mughal, Greta Große, Alina C Hilger, Gabriel C Dworschak, Thomas M Boemers, Ekkehart Jenetzky, Nadine Zwink, Martin Lacher, Dominik Schmidt, Eberhard Schmiedeke, Sabine Grasshoff-Derr, Stefanie Märzheuser, Stefan Holland-Cunz, Mattias Schäfer, Enrika Bartels, Kathleen Keppler, Markus Palta, Johannes Leonhardt, Christina Kujath, Anke Rißmann, Markus M Nöthen, Heiko Reutter, Michael Ludwig.   

Abstract

BACKGROUND: The acronym VATER/VACTERL association describes the combination of at least three of the following cardinal features: vertebral defects, anorectal malformations, cardiac defects, tracheoesophageal fistula with or without esophageal atresia, renal malformations, and limb defects. Although fibroblast growth factor-8 (FGF8) mutations have mainly found in patients with Kallmann syndrome, mice with a hypomorphic Fgf8 allele or complete gene invalidation display, aside from gonadotropin-releasing hormone deficiency, parts or even the entire spectrum of human VATER/VACTERL association.
METHODS: We performed FGF8 gene analysis in 49 patients with VATER/VACTERL association and 27 patients presenting with a VATER/VACTERL-like phenotype (two cardinal features).
RESULTS: We identified two heterozygous FGF8 mutations in patients displaying either VATER/VACTERL association (p.Gly29_Arg34dup) or a VATER/VACTERL-like phenotype (p.Pro26Leu) without limb anomalies. Whereas the duplication mutation has not been reported before, p.Pro26Leu was once observed in a Kallmann syndrome patient. Both our patients had additional bilateral cryptorchidism, a key phenotypic feature in males with FGF8 associated Kallmann syndrome. Each mutation was paternally inherited. Besides delayed puberty in both and additional unilateral cryptorchidism in one of the fathers, they were otherwise healthy. Serum hormone levels downstream the gonadotropin-releasing hormone in both patients and their fathers were within normal range.
CONCLUSION: Our results suggest FGF8 mutations to contribute to the formation of the VATER/VACTERL association. Further studies are needed to support this observation.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  FGF8; Kallmann syndrome; VACTERL/VATER association; anorectal malformation; cryptorchidism; fibroblast growth factor; hypergonadotropic hypogonadism

Mesh:

Substances:

Year:  2014        PMID: 25131394     DOI: 10.1002/bdra.23278

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  8 in total

Review 1.  Underlying genetic factors of the VATER/VACTERL association with special emphasis on the "Renal" phenotype.

Authors:  Heiko Reutter; Alina C Hilger; Friedhelm Hildebrandt; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2016-02-08       Impact factor: 3.714

2.  Targeted Resequencing of 29 Candidate Genes and Mouse Expression Studies Implicate ZIC3 and FOXF1 in Human VATER/VACTERL Association.

Authors:  Alina C Hilger; Jan Halbritter; Tracie Pennimpede; Amelie van der Ven; Georgia Sarma; Daniela A Braun; Jonathan D Porath; Stefan Kohl; Daw-Yang Hwang; Gabriel C Dworschak; Bernhard G Hermann; Anna Pavlova; Osman El-Maarri; Markus M Nöthen; Michael Ludwig; Heiko Reutter; Friedhelm Hildebrandt
Journal:  Hum Mutat       Date:  2015-09-14       Impact factor: 4.878

3.  Loss-of-function mutations in FGF8 can be independent risk factors for holoprosencephaly.

Authors:  Sungkook Hong; Ping Hu; Erich Roessler; Tommy Hu; Maximilian Muenke
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

4.  Genetic Testing in a Cohort of Complex Esophageal Atresia.

Authors:  Eliane Beauregard-Lacroix; Jessica Tardif; Emmanuelle Lemyre; Zoha Kibar; Christophe Faure; Philippe M Campeau
Journal:  Mol Syndromol       Date:  2017-06-16

Review 5.  Involvement of Fibroblast Growth Factors and Their Receptors in Epididymo-Testicular Descent and Maldescent.

Authors:  Faruk Hadziselimovic
Journal:  Mol Syndromol       Date:  2016-02-02

6.  Exome survey of individuals affected by VATER/VACTERL with renal phenotypes identifies phenocopies and novel candidate genes.

Authors:  Caroline M Kolvenbach; Amelie T van der Ven; Franziska Kause; Shirlee Shril; Marcello Scala; Dervla M Connaughton; Nina Mann; Makiko Nakayama; Rufeng Dai; Thomas M Kitzler; Ronen Schneider; Luca Schierbaum; Sophia Schneider; Andrea Accogli; Annalaura Torella; Gianluca Piatelli; Vincenzo Nigro; Valeria Capra; Bernd Hoppe; Stefanie Märzheuser; Eberhard Schmiedeke; Heidi L Rehm; Shrikant Mane; Richard P Lifton; Gabriel C Dworschak; Alina C Hilger; Heiko Reutter; Friedhelm Hildebrandt
Journal:  Am J Med Genet A       Date:  2021-08-02       Impact factor: 2.578

Review 7.  The genetic landscape and clinical implications of vertebral anomalies in VACTERL association.

Authors:  Yixin Chen; Zhenlei Liu; Jia Chen; Yuzhi Zuo; Sen Liu; Weisheng Chen; Gang Liu; Guixing Qiu; Philip F Giampietro; Nan Wu; Zhihong Wu
Journal:  J Med Genet       Date:  2016-04-15       Impact factor: 6.318

Review 8.  Inhibin B in healthy and cryptorchid boys.

Authors:  Susanna Esposito; Marta Cofini; Donato Rigante; Alberto Leonardi; Laura Lucchetti; Clelia Cipolla; Lucia Lanciotti; Laura Penta
Journal:  Ital J Pediatr       Date:  2018-07-16       Impact factor: 2.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.